As of 2026-06-18, the Relative Valuation of StageZero Life Sciences Ltd (SZLS.TO) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of StageZero Life Sciences Ltd based on Relative Valuation is -122.3%.
The range of the Relative Valuation is (0.01) - (0.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.4x - 0.7x | 0.6x |
| Forward P/E multiples | 0.4x - 0.7x | 0.6x |
| Fair Price | (0.01) - (0.01) | (0.01) |
| Upside | -117.9% - -126.8% | -122.3% |
| Date | P/E |